SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Trading Update

15 Jul 2019 07:00

RNS Number : 4376F
The Mission Marketing Group PLC
15 July 2019
 

 

 

 

The Mission Marketing Group plc 

 

Trading update and notice of interim results

  

The Mission Marketing Group plc ("themission", "the Company" or "the Group", AIM: TMMG), the technology-embraced marketing communications and advertising group, today issues a trading update for the six months ended 30 June 2019.

 

The Board is pleased to report that the Group expects to report results for the first half of the year in line with its KPI targets of revenue growth of 5% and profit* growth of 10% from continuing operations**, continuing the Group's track record of growth over the past eight years.

 

The Group made no new acquisitions in the period but settled £3.1m of obligations in relation to acquisitions made in prior years. The Group's net bank debt at 30 June 2019 was £5.2m (30 June 2018: £7.8m) and the Group's debt leverage ratio (the ratio of net bank debt to EBITDA) reduced further, to x0.5 on a comparable, pre-IFRS 16, basis (30 June 2018: x0.7) and to x0.9 on an IFRS 16 basis (30 June 2018: x1.3).

 

As in previous years, the Board expect the Group's results for the year to 31 December 2019 to again have a significant bias towards the second half.

 

The Board intends to announce the Group's interim results on 25 September 2019.

 

* Headline profit before tax, calculated excluding the profit/loss on investments, acquisition-related items and start-up losses

** Continuing operations exclude the results from BroadCare, sold on 12 November 2018

 

Impact of the adoption of IFRS 16: Leases

The Group has implemented IFRS 16: Leases using the full retrospective approach with effect from 1 January 2018. The impact of the new accounting standard is that assets and liabilities as at the transition date of 1 January 2018 will increase by approximately £8m for assets previously accounted for as operating leases. The impact on profit before taxation is insignificant but approximately £2.6m of operating lease expenses will be reclassified as depreciation and interest charges in the full year, and £1.3m in each of the six month periods ended 30 June 2018 and 2019. Accordingly, EBITDA will increase by a corresponding amount.

 

Enquiries:

David Morgan, Chairman

James Clifton, Chief Executive

Peter Fitzwilliam, Finance Director

The Mission Marketing Group plc

 

 

020 7462 1415

 

 

Mark Percy / James Thomas (Corporate Advisory)

 

Shore Capital (Nomad and Broker)

020 7408 4090

 

themission is a network of entrepreneurial marketing communications Agencies employing over 1,000 people in the UK, Asia and US, working together to provide Clients with the expertise and resource to make them more successful in today's dynamic environment.

 

www.themission.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUUOVRKSABAAR
Date   Source Headline
19th Sep 20137:00 amRNSInterim results for the six months to 30 June 2013
30th Aug 20137:00 amRNSNotice of Interim Results
19th Jul 20137:00 amRNSDirector Exercise of Options & EBT dealing
17th Jul 20137:00 amRNSDirector Dealing
16th Jul 20137:00 amRNSDirectors' Exercise of Options
12th Jul 20137:00 amRNSDirector/PDMR Shareholding
11th Jul 20134:11 pmRNSAnnual LTIP Awards and Vesting; EBT Share Dealings
11th Jul 20137:00 amRNSDirector/PDMR Shareholding
10th Jul 20137:00 amRNSTrading Update
17th Jun 201312:30 pmRNSResult of AGM
12th Apr 20134:45 pmRNSDirector/PDMR Shareholding
11th Apr 20134:55 pmRNSDirector Dealing
10th Apr 20137:00 amRNSDirector Shareholding
3rd Apr 20137:00 amRNSDirector/PDMR Shareholding
28th Mar 20137:02 amRNSDirectors' Dealing
27th Mar 20134:10 pmRNSRegistered Office & Availability of Annual Report
25th Mar 20137:00 amRNSFinal Results
22nd Mar 20138:36 amRNSReplacement Notice of Results
22nd Mar 20137:00 amRNSNotice of Results
6th Mar 20137:00 amRNSDirectorate Change
1st Mar 20137:00 amRNSDirectorate Change
28th Jan 20137:00 amRNSTrading Update
25th Jan 20137:00 amRNSNew Client win and further expansion
9th Nov 20127:00 amRNSDirector/PDMR Shareholding
5th Nov 20127:00 amRNSDirector/PDMR Shareholding
19th Oct 201211:44 amRNSHolding(s) in Company
16th Oct 20122:59 pmRNSHolding(s) in Company
12th Oct 20127:00 amRNSAcquisition, Placing and Board Appointment
24th Sep 20127:00 amRNSAcquisition of Addiction Worldwide
19th Sep 20128:19 amRNSHalf Yearly Report
14th Sep 20123:14 pmRNSNotice of Half Year Results
20th Jul 20127:00 amRNSIssue of LTIP Awards
18th Jul 20127:01 amRNSPre Close Trading Update
18th Jul 20127:00 amRNSChange of Adviser
18th Jun 20121:03 pmRNSResult of AGM
18th Jun 201212:00 pmRNSDirectorate Change
31st May 20121:30 pmRNSContract Award
14th May 20124:04 pmRNSDirector/PDMR Shareholding
8th May 20122:01 pmRNSDirector/PDMR Shareholding
4th May 20122:47 pmRNSDirector/PDMR Shareholding
1st May 20127:00 amRNSDirector/PDMR Shareholding
16th Apr 20123:34 pmRNSHolding(s) in Company
27th Mar 20127:00 amRNSFinal Results
22nd Mar 20127:00 amRNSNotice of Results
26th Jan 20127:00 amRNSTrading Statement
24th Jan 20127:00 amRNSDirector/PDMR Shareholding
6th Jan 20129:13 amRNSDirector/PDMR Shareholding
21st Nov 20114:17 pmRNSDirector/PDMR Shareholding
3rd Oct 20112:44 pmRNSDirector/PDMR Shareholding
30th Sep 20117:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.